The growing importance of self-injectable medications for the treatment of type 2 diabetes mellitus (T2DM) parallels that for other diseases. This is an especially significant trend, since patients are increasingly self-managing their diseases in the outpatient setting. This makes it necessary for primary care physicians to become more familiar with the role and use of injectable agents for T2DM and to overcome the negative perceptions of injectable therapies.
Medical Education Library
Optimizing the Use of Injectable Therapies for Type 2 Diabetes
This supplement was sponsored by Primary Care Education Consortium and Primary Care Metabolic Group and is supported by funding from Novo Nordisk, Inc. It was edited and peer reviewed by The Journal of Family Practice.
